These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20924284

  • 41. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM, Farrelly LW, Viti D, Redmond ST, Hutchison F, Ruiz P, Manning P, Connor J, Gilkeson GS.
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [Abstract] [Full Text] [Related]

  • 42. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

  • 43. Cordyceps cicadae ameliorates inflammatory responses, oxidative stress, and fibrosis by targeting the PI3K/mTOR-mediated autophagy pathway in the renal of MRL/lpr mice.
    Yang F, Zhang Y, Dong L, Song Z.
    Immun Inflamm Dis; 2024 Jan; 12(1):e1168. PubMed ID: 38270299
    [Abstract] [Full Text] [Related]

  • 44. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
    Liao R, Liu Q, Zheng Z, Fan J, Peng W, Kong Q, He H, Yang S, Chen W, Tang X, Yu X.
    PLoS One; 2015 Jan; 10(7):e0132724. PubMed ID: 26161538
    [Abstract] [Full Text] [Related]

  • 45. Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis.
    Cao H, Liang J, Liu J, He Y, Ke Y, Sun Y, Jiang S, Lin J.
    Front Immunol; 2021 Jan; 12():720877. PubMed ID: 34867948
    [Abstract] [Full Text] [Related]

  • 46. A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size.
    Lei Y, Sehnert B, Voll RE, Jacobs-Cachá C, Soler MJ, Sanchez-Niño MD, Ortiz A, Bülow RD, Boor P, Anders HJ.
    Kidney Int; 2021 Jun; 99(6):1331-1341. PubMed ID: 33607177
    [Abstract] [Full Text] [Related]

  • 47. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
    Zhao C, Gu Y, Chen L, Su X.
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
    [Abstract] [Full Text] [Related]

  • 48. Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice.
    Kim YE, Lee EJ, Kim K, Kim DH, Jeong MR, Yu J, Hong S, Lee CK, Yoo B, Kim YG.
    Front Immunol; 2023 Dec; 14():1148574. PubMed ID: 37744355
    [Abstract] [Full Text] [Related]

  • 49. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC, Wu D, Wu HL, Li HY, Yang C, Su HY, Liu ZJ, Huang XR, Lu X, Huang LF, Zhu SP, Pan QJ, An N, Liu HF.
    Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
    [Abstract] [Full Text] [Related]

  • 50. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
    Liu J, Ma Q, Sun Q, Luo Q, Wang Y, Wang C, Zhu A, Zhao L, Yin L, Lou J, Dong Y, Qiu P.
    Oxid Med Cell Longev; 2022 Apr; 2022():4301033. PubMed ID: 35855861
    [Abstract] [Full Text] [Related]

  • 51. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
    Zhao XY, Li SS, He YX, Yan LJ, Lv F, Liang QM, Gan YH, Han LP, Xu HD, Li YC, Qi YY.
    Ann Rheum Dis; 2023 Oct; 82(10):1328-1340. PubMed ID: 37487609
    [Abstract] [Full Text] [Related]

  • 52. Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice.
    Mederle K, Meurer M, Castrop H, Höcherl K.
    Am J Physiol Renal Physiol; 2015 Aug 15; 309(4):F332-40. PubMed ID: 26017977
    [Abstract] [Full Text] [Related]

  • 53. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
    Du Y, Zhang W, Liu S, Feng X, Gao F, Liu Q.
    Biochem Biophys Res Commun; 2018 Sep 03; 503(1):177-180. PubMed ID: 29885836
    [Abstract] [Full Text] [Related]

  • 54. Expression of platelet-derived growth factor in lupus nephritis in MRL/MpJ-1pr/1pr mice.
    Entani C, Izumino K, Takata M, Futamura A, Nakagawa Y, Inoue H, Iida H.
    Nephron; 1997 Sep 03; 77(1):100-4. PubMed ID: 9380223
    [Abstract] [Full Text] [Related]

  • 55. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis.
    Tomasoni S, Noris M, Zappella S, Gotti E, Casiraghi F, Bonazzola S, Benigni A, Remuzzi G.
    J Am Soc Nephrol; 1998 Jul 03; 9(7):1202-12. PubMed ID: 9644630
    [Abstract] [Full Text] [Related]

  • 56. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.
    Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, Gilkeson GS.
    J Immunol; 2000 Feb 01; 164(3):1498-504. PubMed ID: 10640767
    [Abstract] [Full Text] [Related]

  • 57. Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation.
    Wang H, Shen M, Ma Y, Lan L, Jiang X, Cen X, Guo G, Zhou Q, Yuan M, Chen J, Xia H, Xiao L, Han F.
    Kidney Int; 2024 Apr 01; 105(4):759-774. PubMed ID: 38296028
    [Abstract] [Full Text] [Related]

  • 58. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 59. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
    Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.
    Clin Immunol; 2016 Aug 01; 169():139-147. PubMed ID: 27392463
    [Abstract] [Full Text] [Related]

  • 60. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis.
    Kim CS, Mathew AP, Vasukutty A, Uthaman S, Joo SY, Bae EH, Ma SK, Park IK, Kim SW.
    J Nanobiotechnology; 2021 Apr 17; 19(1):109. PubMed ID: 33865397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.